SCHEMBL10320307

SCHEMBL10320307

CC1Cc2c(C(=O)O)ccc(N)c2O1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.64
TDP1 Q9NUW8 3/20 0.38
MAOA P21397 3/20 0.38
MAPK1 P28482 1/20 0.37
KDM4E B2RXH2 4/20 0.36
KMT2A Q03164 2/20 0.36
GFER P55789 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
IP6K1 Q92551 1/20 0.36
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.35
APEX1 P27695 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7436052 0.88 PARP1 (0.78) PARP1TDP1MAOAMAPK1KDM4E
SCHEMBL9329830 0.87 PARP1 (0.58) PARP1TDP1MAOAMAPK1KDM4E
SCHEMBL10321219 0.84 PARP1 (0.59) PARP1MAOAKDM4EALDH1A1HPGD
SCHEMBL27847947 0.81 PARP1 (0.43) PARP1TDP1MAPK1KDM4EKMT2A
SCHEMBL10318917 0.77 PARP1 (0.40) PARP1TDP1MAPK1KDM4EKMT2A
SCHEMBL7129014 0.75 PARP1 (0.52) PARP1TDP1MAOAMAPK1KDM4E
SCHEMBL10831325 0.75 PARP1 (0.51) PARP1MAOAKDM4EALDH1A1HPGD
SCHEMBL11957651 0.75 PARP1 (0.49) PARP1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7332542 0.74 PARP1 (0.55) PARP1TDP1MAPK1KDM4EKMT2A
SCHEMBL18181796 0.73 PARP1 (0.50) PARP1MAOAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2481739-B1 DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF JIANGSU HANSOH PHARMACEUTICAL CO LTD (CN) 2016-12-14 EP disclosed
EP-2481739-A1 DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF Jiangsu Hengrui Medicine Co., Ltd. (CN) 2012-08-01 EP disclosed
US-20120184543-A1 DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184543-A1 DIHYDROPTERIDINONE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF PLK2, PLK3, DMPK PARP1 1509/4885TDP1 2733/4885MAOA 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.